Tag: demand
Cambrex looks to fill ‘onshore’ API manufacturing demand with $50M expansion...
With the COVID-19 pandemic nearing its second year in the U.S., lawmakers have banged the drum on boosting "onshore" production of key pharmaceuticals and ingredients...
FiercePharmaAsia—Biocon, Mylan’s Lantus copy; Samsung rides COVID demand; Adlai Nortye’s C...
Mylan and Biocon will launch Semglee, their biosimilar of Sanofi's Lantus, at a discount. Samsung Biologics' $2 billion "Super Plant" expansion is the result...
